Old Web
English
Sign In
Acemap
>
authorDetail
>
Martin Sebastian Olivo
Martin Sebastian Olivo
Daiichi Sankyo
Medicine
Triple-negative breast cancer
Oncology
Internal medicine
Sacituzumab govitecan
4
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Assessment of sacituzumab govitecan (SG) in patients with prior neoadjuvant/adjuvant chemotherapy in the phase 3 ASCENT study in metastatic triple-negative breast cancer (mTNBC).
2021
Journal of Clinical Oncology
Lisa A. Carey
Delphine Loirat
Kevin Punie
Aditya Bardia
Véronique Diéras
Florence Dalenc
Jennifer R. Diamond
Christel Fontaine
Grace Wang
Hope S. Rugo
Sara A. Hurvitz
Kevin Kalinsky
Joyce OShaughnessy
Sibylle Loibl
Luca Gianni
Martine Piccart-Gebhart
Quan Hong
Martin Sebastian Olivo
Loretta M. Itri
Javier Cortes
Show All
Source
Cite
Save
Citations (0)
Outcomes in patients (pts) aged ≥65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC).
2021
Journal of Clinical Oncology
Kevin Kalinsky
Mafalda Oliveira
Tiffany A. Traina
Sara M. Tolaney
Delphine Loirat
Kevin Punie
Sara A. Hurvitz
Filipa Lynce
Erika Hamilton
Rita Nanda
Lowell L. Hart
Paul Richards
Zulfiqar A. Malik
Hope S. Rugo
Véronique Diéras
Aditya Bardia
Quan Hong
Martin Sebastian Olivo
Loretta M. Itri
Sibylle Loibl
Show All
Source
Cite
Save
Citations (1)
Assessment of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) cohort by agent in the phase 3 ASCENT study of patients (pts) with metastatic triple-negative breast cancer (mTNBC).
2021
Journal of Clinical Oncology
Joyce OShaughnessy
Kevin Punie
Mafalda Oliveira
Filipa Lynce
Sara M. Tolaney
Florence Dalenc
Priyanka Sharma
Michaela L. Tsai
Aditya Bardia
Javier Cortes
Michael A. Danso
Stéphanie Henry
Alejandra T. Perez
Sara A. Hurvitz
Kevin Kalinsky
Quan Hong
Martin Sebastian Olivo
Loretta M. Itri
Hope S. Rugo
Show All
Source
Cite
Save
Citations (0)
Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in breast cancer patients: Phase 1 dose escalation study.
2018
Journal of Clinical Oncology
Takahiro Kogawa
Kan Yonemori
Norikazu Masuda
Shunji Takahashi
Masato Takahashi
Hirotaka Iwase
Takahiro Nakayama
Toshiaki Saeki
Tatsuya Toyama
Toshimi Takano
Hiroshi Onuma
Hayao Ogawa
Yoshimi Tanaka
Yoshiko Igari
Masahiro Sugihara
Michele Vigliotti
Channing Yu
Martin Sebastian Olivo
Suguru Ueno
Hiroji Iwata
Show All
Source
Cite
Save
Citations (9)
1